Home/Filings/4/0001562180-19-003561
4//SEC Filing

Ross Leonard S 4

Accession 0001562180-19-003561

CIK 0001314102other

Filed

Jun 16, 8:00 PM ET

Accepted

Jun 17, 5:41 PM ET

Size

9.2 KB

Accession

0001562180-19-003561

Insider Transaction Report

Form 4
Period: 2019-06-14
Ross Leonard S
Corporate Controller
Transactions
  • Tax Payment

    Common Stock

    2019-06-14$1.53/sh2,394$3,66385,338 total
  • Exercise/Conversion

    Common Stock

    2019-06-14+8,28087,732 total
  • Exercise/Conversion

    Restricted Stock Units

    2019-06-148,28016,560 total
    Exercise: $0.00Common Stock (8,280 underlying)
Footnotes (3)
  • [F1]Restricted stock units convert into common stock on a one-for-one basis.
  • [F2]No shares were sold - these shares were withheld by the issuer to satisfy tax withholding requirements in connection with the Reporting Person's exercise of his withholding right following the vesting of the restricted stock units
  • [F3]On June 14, 2018, the reporting person was granted 24,840 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date.

Issuer

EyePoint Pharmaceuticals, Inc.

CIK 0001314102

Entity typeother

Related Parties

1
  • filerCIK 0001458753

Filing Metadata

Form type
4
Filed
Jun 16, 8:00 PM ET
Accepted
Jun 17, 5:41 PM ET
Size
9.2 KB